Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 5, 2004, Pages 1531-1543

  Wehrwein, Erica ^a   Thompson, Sean A ^a   Coulibaly, Sylvie F ^a   Linn, David M ^a   Linn, Cindy L ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINE; ALPHA BUNGAROTOXIN; ANTIBODY; ANTIBODY THY 1 1; CALCEIN; CHOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; KAINIC ACID; METHYLLYCACONITINE; MUSCARINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; BUNGAROTOXIN; FLUORESCEIN DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL COUNT; CELL ISOLATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; GLAUCOMA; LONG TERM EXPOSURE; MODIFIED PANNING TECHNIQUE; NERVE CELL GROWTH; NEURITE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; SWINE; ANIMAL; CELL CULTURE; CELL PROTECTION; CELL SEPARATION; CYTOLOGY; DRUG EFFECT; METABOLISM; METHODOLOGY;

ACETYLCHOLINE; ANIMALS; BUNGAROTOXINS; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; CHOLINE; CYTOPROTECTION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FLUORESCEINS; GLUTAMIC ACID; NEUROPROTECTIVE AGENTS; NICOTINE; RECEPTORS, NICOTINIC; RETINAL GANGLION CELLS; SWINE;

EID: 2442690669     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0406     Document Type: Article

References (87)

1. Choi DW. Glutamate neurotoxicity and disease of the nervous system. Neuron. 1988;1:623-634.
2. Romano C, Chen Q, Olney JW. The intact (ex vivo) retina as a model system for the study of excitotoxicity. Prog Ret Eye Res. 1998;17:465-483.
3. Quigley HA. Neuronal death in glaucoma. Prog Ret Eye Res. 1998;18:39-57.
4. Lafuente MP, Villegas-Perez PM, Sobrado-Calvo P, Garcia-Aviles A, Miralles de Imperial J, Vidal-Sanz M. Neuroprotective effects of alpha (2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci. 2001;42:2074-2084.
5. Vickers BM, Schumer RA, Podos SM, Wang RF, Riederer BM, Morrison JH. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 1995;680:23-35.
6. Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE. Vitreous body glutamate concentration in dogs with glaucoma. Amer J Vis Res. 1997;58:864-867.
7. Dkhissi O, Chanut E, Wasowicz M, et al. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quaff with a glaucoma-like disorder. Invest Ophthalmol Vis Sci. 1999;40:990-995.
8. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
9. Lam TT, Abler AS, Kwong JMK, Tso MOM. N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci. 1999;40:2391-2397.
10. Hamassaki-Britto DE, Hermans-Borgmeyer I, Heinemann S, Hughes TE. Expression of glutamate receptor genes in the mammalian retina: the localization of GluR1 through GluR7 mRNAs. J Neurosci. 1993;13:1888-1898.
11. Watanabe M, Mishina M, Inoue Y. Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J Comp Neurol. 1994;345:314-319.
12. Goebel DJ, Aurelia JL, Tai Q, Jojich L, Poosch MS. Immunocytochemical localization of the NMDA-R2A receptor subunit in the cat retina. Brain Res. 1998;808:141-154.
13. Lin B, Martin PR, Grunert U. Expression and distribution of ionotropic glutamate receptor subunits on parasol ganglion cells in the primate retina. Vis Neurosci. 2002;4:453-465.
14. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484-491.
15. Dreyer EB, Pan Z-H, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. NeuroReport. 1994;5:629-631.
16. Hahn JS, Aizenman E, Lipton SA. Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular calcium: toxicity is blocked by the N-methyl-D-aspartate antagonists MK-801. Proc Nat Acad Sci. 1988;85:6556-6560.
17. Kitano S, Morgan J, Caprioli J. Hypoxic and excitototoxic damage to cultured rat retinal ganglion cells. Exp Eye Res. 1996;63:105-112.
18. Mosinger JL, Prince MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol. 1991;113:10-17.
19. Otori Y, Wei JY, Barnstable CJ. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 1998;39:972-981.
20. Marin P. Maus M, Desagher S, Glowinski J, Premont J. Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport. 1994;5:1851-1855.
21. Shimohama S, Akaike A, Kimura J. Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann N Y Acad Sci. 1996;17:356-361.
22. Kaneko S, Maeda T, Kume T, et al. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors. Brain Res. 1997;765:135-140.
23. 2+ dependent mechanism. Neuropharm. 2000;39:2799-2807.
24. Famiglietti EV Jr. Starburst amacrine cells and cholinergic neurons: mirror-symmetric on and off amacrine cells of rabbit retina. Brain Res. 1983;261:138-144.
25. Masland RH, Mills JW, Hayden SA. Acetylcholine-synthesizing amacrine cells: identification and selective staining by using radioautography and fluorescent markers. Proc R Soc Lond B Biol Sci. 1984;223:79-100.
26. Mariani AP, Hersh LB. Synaptic organization of cholinergic amacrine cells in the rhesus monkey retina. J Comp Neurol. 1988;267:269-280.
27. Keyser KT, Hughes TE, Whiting PJ, Lindstrom JM, Karten HJ. Cholinoceptive neurons in the retina of the chick: an immunohistochemical study of the nicotinic acetylcholine receptors. Vis Neurosci. 1988;1:349-366.
28. Whiting PJ, Schoepfer R, Conroy WG, et al. Expression of nicotinic acetylcholine receptor subtypes in brain and retina. Mol Brain Res. 1991;10:61-70.
29. Keyser KT, Britto LGR, Schoepfer R, et al. Three subtypes of a-Bgt-sensitive nicotinic Ach receptors are expressed in chick retina. J Neurosci. 1993;13:442-454.
30. Kaneda M, Hashimoto M, Kaneko A. Neuronal nicotinic acetylcholine receptors of ganglion cells in the cat retina. Jpn J Physiol. 1995;45:491-508.
31. Reed BT, Amthor FR, Keyser KT. Rabbit retinal ganglion cell responses mediated by alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors. Vis Neurosci. 2002;19:427-438.
32. Guenther E, Schmid S, Grantyn R, Zrenner E. In vitro identification of retinal ganglion cells in culture without the need of dye labeling. J Neurosci methods. 1994;51:177-181.
33. Barres BA, Silverstein BE, Corey DP, Chun LLY. Immunological, morphological and electrophysiological variation among retinal ganglion cells purified by panning. Neuron. 1988;1:791-803.
34. Bozyczko-Coyne D, McKenna BW, Connors TJ, Neff NT. A rapid fluorometric assay to measure neuronal survival in vitro. J Neurosci Methods. 1993;50:205-216.
35. Barnstable CJ, Drager UC. Thy-1 antigen: a ganglion cell specific marker in rodent retina. Neurosci. 1984;11:847-855.
36. Kawasaki A, Han MH, Wei JY, Hirata K, Otori Y, Barnstable CJ. Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2002;43:1835-1842.
37. Luo X, Heidinger V, Picaud S, et al. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci. 2001;42:1096-1106.
38. Britto LR, Rogers SW, Hamassaki-Britto DE, Duvoisin RM. Nicotinic acetylcholine receptors in the ground squirrel retina: localization of the beta 4 subunit by immunohistochemistry and in situ hybridization. Vis Neurosci. 1994;11:569-577.
39. Araki CM, Pires RS, Britto LR, Lindstrom JM, Karten HJ, Hamassaki-Britto DE. Differential co-localization of nicotinic acetylcholine receptor subunits with calcium-binding proteins in retinal ganglion cells. Brain Res. 1997;774:250-255.
40. Chen D, Patrick JW. The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit. J Biol Chem. 1997;272:24024-24029.
41. Jonnala RR, Graham JH III, Terry AV Jr, Beach JW, Young JA, Buccafusco JJ. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. Synapse. 2003;47:262-269.
42. Alkondon M, Pereira EFR, Wonnacott S, Albuquerque EX. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol. 1992;4:802-808.
43. Klink R, deKerchove d'Exaerde A, Zoli M, Changeux J-P. Molecular and physiological diversity of nicotinic ACh receptors in the midbrain dopaminergic nuclei. J. Neurosci. 2001;21:1452-1463.
44. Yum L, Wolf KM, Chiappinelli VA. Nicotinic acetylcholine receptors in separate brain regions exhibit different affinities for methyllycaconitine. Neurosci. 1996;72:545-555.
45. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci. 2002;22;8785-8789.
46. Vailati S, Moretti M, Longhi R, Rovati GE, Clementi F, Gotti C. Developmental expression of heteromeric nicotinic receptor subtypes in chick retina. Mol Pharmacol. 2003;63:1329-1337.
47. Papke RL, Bencherif M, Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci Lett. 1996;213:201-204.
48. Papke RL, Porter Papke JK. Comparative pharmacology of rat and human alpha 7 nAChR conducted with net charge analysis. Br J Pharmacol. 2002;137:49-61.
49. Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci. 1997;9:2734-2742.
50. Zwart R, Vijverberg HP. Potentiation and inhibition of neuronal alpha4beta4 nicotinic acetylcholine by choline. Eur J Pharmacol. 393:209-214, 2000.
51. Sinclair CM, Bartlett PF, Greig DI, Jeffrey PL. Distribution of Thy-1 in the avian nervous system: immunohistochemical and absorption analyses with monoclonal antibody. Brain Res. 1986;398:91-105.
52. Saleh M, Bartlett PF. Isolation of a Thy-1-like glycoprotein from cat brain: distribution in retina and brain defined by monoclonal antibodies. J Neurosci Res. 1989;23:152-161.
53. Vaughan DK, Erickson PA, Fisher SK. Glial fibrillary acidic protein (GFAP) immunoreactivity in rabbit retina: effect of fixation. Exp Eye Res. 1990;50:385-392.
54. Wygnanski T, Desatnik H, Quigley HA, Glovinsky Y. Comparison of ganglion cell loss and cone loss in experimental glaucoma. Am J Ophthalmol. 1995;120:184-189.
55. Linn DM, Massey SC. Acetylcholine release from the rabbit retina mediated by NMDA receptors. J Neurosci. 1991;11:123-133.
56. Muller F, Greferath U, Wassle H, Wisden W, Seeburg P. Glutamate receptor expression in the rat retina. Neurosci Lett. 1992;138:179-182.
57. Brandstatter JH, Hartveit E, Sassoe-Pognetto M, Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci. 1994;6:1100-1112.
58. Koh DS, Geiger JRP, Jonas P, Sakmann B. Calcium permeable AMPA and NMDA receptor channels in basket cells of rat hippocampal dentate gyrus. J Physiol. 1995;485:383-402.
59. Otis TS, Raman IM, Trussell LO. AMPA receptors with high calcium permeability mediate synaptic transmission in the avian auditory pathway. J Physiol. 1995;482:309-315.
60. Burnashev N. Calcium permeability of ligand-gated channels. Cell Calcium. 1998;24:325-332.
61. Budd SL, Tenneti L, Lishnak T, Lipton SA. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci USA. 2000;97:6161-6166.
62. Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
63. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995;92:7162-7166.
64. Leifer D, Krainc D, Yu YT, et al. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc Natl Acad Sci USA. 1993;90:1546-1550.
65. Okamoto S, Krainc D, Sherman K, Lipton SA. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci USA. 2000;97:7561-7566.
66. Pavlovic D, Andersen N, Mandrup-Poulsen T, Zizirik DL. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic b-cells. Eur Cytokine Network. 2000;11:267-274.
67. Shaw S, Bencherif M, Marrero MB. Janus kinase 2, an early target of alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against Aβ-(1-42) amyloid. J Biol Chem. 2002;277:44920-44924.
68. Tenneti L, D'Emilia DM, Troy CM, Lipton SA. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem. 1998;71:946-959.
69. Wein FB, LA Levin. Current understanding of neuroprotection in glaucoma. Curr Opin Ophthalmol. 2002;13:61-67.
70. Ahmed FA, Hegazy K, Chaudhary P, Sharma SC. Neuroprotective effect of alpha (2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Res. 2001;913:133-139.
71. Wood JP, DeSantis L, Chao HM, Osborne NN. Topically applied betaxolol attenuates ischemia-induced effects to rat retina and stimulates BDNF mRNA. Exp Eye Res. 2001;72:79-86.
72. Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci. 2001;42:966-974.
73. Saitoh T, Mishima HK, Shoge K, Ishihara K, Sasa M. Protection against glutamate neurotoxicity in retinal cultures by acidic conditions. Jpn J Pharmacol. 1998;76:87-95.
74. Broide RS, Leslie FM. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol. 1999;20:1-16.
75. Tanaka H, Calderone A, Jover T, et al. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1. Proc Natl Acad Sci USA. 2002;99:2362-2367.
76. Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci. 2001;21:4564-4571.
77. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994;368:339-342.
78. Schwartz M. Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine. Invest Ophthal Vis Sci. 2003;44:1407-1411.
79. Donnelly-Roberts DL, Xue IC, Arneric SP, Sullivan JP. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418. Brain Res. 1996;719:36-44.
80. Kihara T, Shimohama S, Sawada H, et al. Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block beta-amyloid-induced neurotoxicity. J Biol Chem. 2001;276:13541-13546.
81. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties and distribution of rat brain alpha7: a nicotinic cation channel highly permeable to calcium. J Neurosci. 1993;13:596-604.
82. Sargent PB. The diversity of neuronal nicotinic acetylcholine receptor. Ann Rev Neurosci. 1993;16:403-443.
83. Linn DM, Cortes-Borgos L, McFinton P, et al. Characterization and expression of nicotinic ACh receptors in the mammalian retina. Invest Ophthalmol Vis Sci Abst. 2002;43:731.
84. Reed BT, Strang CE, Brockway LM, Amthor FR, Keyser KT. MLA Sensitivity in the rabbit retina is mediated by functional alpha7 nAChRS. Invest Ophthalmol Vis Sci Abst. 2002;43:4770.
85. Rogers M, Dani JA. Comparison of quantitative calcium flux through NMDA, ATP and ACh receptor channels. Biophys J. 1995;68:501-506.
86. Ragozzino D, Barabino B, Fucile S, Eusebi F. Calcium permeability of mouse and chick nicotinic acetylcholine receptors expressed in transiently transfected human cells. J Physiol. 1998;507:749-757.
87. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci. 2001;21:4125-4133.